Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 5/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.32 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27245246 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL19356691 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL19356606 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL27245245 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL612829 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL610669 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL19356773 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL610798 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL15847432 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 | |
| SCHEMBL27028330 | 0.97 | TSHR (0.44) | LMNATSHRTHRBEPHX1SLC22A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11059920-B2 | Process for producing high cis-1,4-polydiene with lanthanide-based catalyst compositions | BRIDGESTONE CORPORATION (JP) | 2021-07-13 | — | — | US | claimed |
| US-20190169330-A1 | Process For Producing High Cis-1,4-Polydiene With Lanthanide-Based Catalyst Compositions | BRIDGESTONE CORPORATION (JP) | 2019-06-06 | — | — | US | claimed |
| EP-3491030-A1 | PROCESS FOR PRODUCING HIGH CIS-1,4-POLYDIENE WITH LANTHANIDE-BASED CATALYST COMPOSITIONS | Bridgestone Corporation (JP) | 2019-06-05 | — | — | EP | claimed |
| WO-2018022994-A1 | PROCESS FOR PRODUCING HIGH CIS-1,4-POLYDIENE WITH LANTHANIDE-BASED CATALYST COMPOSITIONS | BRIDGESTONE CORPORATION (JP) | 2018-02-01 | — | — | WO | claimed |
| US-20150329727-A1 | A COATING COMPOSITION, A PREPARATION METHOD THEREFORE, AND USE THEREOF | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2015-11-19 | — | — | US | claimed |
| EP-2938753-A1 | A COATING COMPOSITION, A PREPARATION METHOD THEREFORE, AND USE THEREOF | Akzo Nobel Coatings International B.V. (NL) | 2015-11-04 | — | — | EP | claimed |
| WO-2014102166-A9 | A COATING COMPOSITION, A PREPARATION METHOD THEREFORE, AND USE THEREOF | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2014-09-18 | — | — | WO | claimed |
| WO-2014102166-A1 | A COATING COMPOSITION, A PREPARATION METHOD THEREFORE, AND USE THEREOF | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2014-07-03 | — | — | WO | claimed |
| EP-3429980-B1 | SURFACE APPLIED CORROSION INHIBITOR | SIKA TECH AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| US-20260118791-A1 | TONER | CANON KK (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4086705-B1 | TONER | CANON KK (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-4012501-B1 | EXTERNAL ADDITIVE FOR TONER, TONER AND IMAGE FORMING APPARATUS | CANON KK (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260040940-A1 | SEMICONDUCTOR DEVICE HAVING AIR GAP AND METHOD FOR MANUFACTURING THE SAME | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2026-02-05 | — | — | US | disclosed |
| US-12487539-B2 | Fine particle, external additive for toners, and toner | CANON KABUSHIKI KAISHA (JP) | 2025-12-02 | — | — | US | disclosed |
| WO-2000052068-A1 | PROCESS FOR PRODUCING POLYETHYLENE | EASTMAN CHEMICAL COMPANY (US) | 2000-09-08 | — | — | WO | disclosed |
| US-4717770-A | CYCLOHEXANONE OXIME, ZEOLITES, SURFACE TREATMENT WITH ORGANOSILICON OR ORGANOGERMANIUM COMPOUNDS | SUMITOMO CHEMICAL CO., LTD. (JP) | 1988-01-05 | — | — | US | disclosed |
| EP-0236092-A2 | Process for producing e-caprolactam | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-09-09 | — | — | EP | disclosed |
| US-4659792-A | USING COORDINATION, POLYMERIZATION CATALYST CONTAINING TITANIUM, MAGNESIUM, DIESTER, ORGANO ALUMINUM AND ORGANOSILICON COMPOUND | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1987-04-21 | — | — | US | disclosed |
| EP-0125910-B1 | PROCESS FOR PRODUCTION OF 4-METHYL-1-PENTENE POLYMER OR COPOLYMER | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1986-10-08 | — | — | EP | disclosed |
| EP-0125910-A1 | Process for production of 4-methyl-1-pentene polymer or copolymer | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1984-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040940-A1 | SEMICONDUCTOR DEVICE HAVING AIR GAP AND METHOD FOR MANUFACTURING THE SAME | GJB2, GJA1, EPHA4 | LMNA 4141/4885TSHR 319/4885THRB 893/4885 |
| US-20260118791-A1 | TONER | MSR1, H1-2, TAAR1 | LMNA 1670/4885TSHR 165/4885THRB 1009/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.